ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 174 filers reported holding ANACOR PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $4,703,000 | -75.3% | 87,990 | -47.9% | 0.01% | -72.4% |
| Q4 2015 | $19,066,000 | +3.8% | 168,770 | +8.2% | 0.03% | +7.4% |
| Q3 2015 | $18,365,000 | +34.8% | 156,022 | -11.3% | 0.03% | +35.0% |
| Q2 2015 | $13,625,000 | +99.0% | 175,966 | +48.7% | 0.02% | +81.8% |
| Q1 2015 | $6,848,000 | +384.0% | 118,375 | +169.8% | 0.01% | +450.0% |
| Q4 2014 | $1,415,000 | +33.7% | 43,869 | +1.4% | 0.00% | +100.0% |
| Q3 2014 | $1,058,000 | +195.5% | 43,252 | +114.4% | 0.00% | – |
| Q2 2014 | $358,000 | +23.0% | 20,174 | +38.8% | 0.00% | – |
| Q1 2014 | $291,000 | -66.5% | 14,533 | -72.0% | 0.00% | -100.0% |
| Q4 2013 | $869,000 | +62.1% | 51,814 | +2.6% | 0.00% | 0.0% |
| Q3 2013 | $536,000 | – | 50,486 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 5,621,423 | $59,700,000 | 36.62% |
| VHCP Management, LLC | 1,610,856 | $17,107,000 | 9.45% |
| Broadfin Capital, LLC | 1,737,669 | $18,454,000 | 3.28% |
| Consonance Capital Management LP | 737,685 | $7,834,000 | 1.96% |
| Palo Alto Investors LP | 1,600,178 | $16,994,000 | 1.78% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 520,091 | $5,523,000 | 1.06% |
| QVT Financial LP | 1,358,303 | $14,425,000 | 0.98% |
| Lombard Odier Asset Management (USA) Corp | 1,700,000 | $18,054,000 | 0.91% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,702,300 | $18,061,000 | 0.89% |
| Perceptive Advisors | 1,947,736 | $20,684,000 | 0.85% |